MeSH term
Frequency | Condition_Probility | 3T3 Cells | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Animals | 20 | 0.0 |
Cell Line | 5 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Dimerization | 5 | 0.0 |
Homeodomain Proteins/*genetics/*metabolism | 2 | 6.0 |
Humans | 21 | 0.0 |
Mice | 15 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Female | 4 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Homeodomain Proteins/*genetics | 4 | 0.0 |
Male | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Transcription Factors/*genetics | 4 | 0.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Conformation | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Base Sequence | 12 | 0.0 |
Binding Sites | 6 | 0.0 |
*Enhancer Elements (Genetics) | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Tretinoin/pharmacology | 4 | 1.0 |
*Genes, Homeobox | 4 | 1.0 |
Phenotype | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Cell Movement | 2 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Signal Transduction | 4 | 0.0 |
*Trans-Activators | 2 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Trans-Activation (Genetics)/*physiology | 2 | 1.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Homeodomain Proteins/*metabolism | 3 | 2.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
*Gene Expression Regulation, Developmental | 5 | 0.0 |
Mice, Inbred CBA | 3 | 0.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Solutions | 2 | 1.0 |
Time Factors | 3 | 0.0 |
COS Cells | 3 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Genes, Reporter/genetics | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Regulatory Sequences, Nucleic Acid/*genetics | 2 | 2.0 |
Sequence Alignment | 2 | 0.0 |
Transfection/genetics | 2 | 1.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
*Xenopus Proteins | 3 | 0.0 |
Embryonic and Fetal Development/*genetics | 2 | 2.0 |
Homeodomain Proteins/biosynthesis | 2 | 12.0 |
Mutation | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
Tail/*embryology | 2 | 100.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Transfection | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Adult | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Mesoderm/metabolism | 2 | 2.0 |
